1. Home
  2. CNTB vs DOMH Comparison

CNTB vs DOMH Comparison

Compare CNTB & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • DOMH
  • Stock Information
  • Founded
  • CNTB 2012
  • DOMH 1967
  • Country
  • CNTB United States
  • DOMH United States
  • Employees
  • CNTB N/A
  • DOMH N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • DOMH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNTB Health Care
  • DOMH Health Care
  • Exchange
  • CNTB Nasdaq
  • DOMH Nasdaq
  • Market Cap
  • CNTB 114.8M
  • DOMH 94.0M
  • IPO Year
  • CNTB 2021
  • DOMH N/A
  • Fundamental
  • Price
  • CNTB $1.60
  • DOMH $6.28
  • Analyst Decision
  • CNTB Strong Buy
  • DOMH
  • Analyst Count
  • CNTB 2
  • DOMH 0
  • Target Price
  • CNTB $7.50
  • DOMH N/A
  • AVG Volume (30 Days)
  • CNTB 156.9K
  • DOMH 261.5K
  • Earning Date
  • CNTB 09-05-2025
  • DOMH 11-07-2025
  • Dividend Yield
  • CNTB N/A
  • DOMH 8.98%
  • EPS Growth
  • CNTB N/A
  • DOMH N/A
  • EPS
  • CNTB N/A
  • DOMH N/A
  • Revenue
  • CNTB $1,965,000.00
  • DOMH $52,811,000.00
  • Revenue This Year
  • CNTB N/A
  • DOMH N/A
  • Revenue Next Year
  • CNTB N/A
  • DOMH N/A
  • P/E Ratio
  • CNTB N/A
  • DOMH N/A
  • Revenue Growth
  • CNTB N/A
  • DOMH 455.38
  • 52 Week Low
  • CNTB $1.55
  • DOMH $0.83
  • 52 Week High
  • CNTB $2.20
  • DOMH $13.58
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 42.21
  • DOMH 54.75
  • Support Level
  • CNTB $1.55
  • DOMH $5.61
  • Resistance Level
  • CNTB $1.76
  • DOMH $7.18
  • Average True Range (ATR)
  • CNTB 0.18
  • DOMH 0.35
  • MACD
  • CNTB -0.03
  • DOMH -0.40
  • Stochastic Oscillator
  • CNTB 9.92
  • DOMH 87.74

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.

Share on Social Networks: